Lexington, Mass. – December 20, 2018 – Kaleido Biosciences, a healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ, today announced the appointment of three new members to its Board of Directors: Bonnie Bassler, Ph.D., Chair, [...]
Lexington, Mass. – December 3, 2018 – Kaleido Biosciences, a healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ, today announced the appointment of Katharine Knobil, M.D., as chief medical officer (CMO) and head of research [...]
BEDFORD, Mass., August 21, 2018 – Kaleido Biosciences, a clinical-stage healthcare company leading the development of novel chemistries that drive functions of the microbiome organ, today announced that Alison Lawton, Kaleido’s president and chief operating officer (COO), has been appointed [...]
Welcome to the Kaleido Biosciences’ Twitter Feed, @KaleidoBio. We’re excited to connect with you on Twitter and ask that you follow these Community Guidelines to ensure discussions are respectful and on topic. Because the industry in which we operate is highly regulated, there may be some [...]
BEDFORD, Mass., June 25, 2018 – Kaleido Biosciences, a clinical-stage healthcare company leading the development of novel chemistries to drive functions of the microbiome organ, today announced that it has closed $101 million in an oversubscribed Series C financing. Several new investors [...]
BEDFORD, Mass., April 23, 2018 – Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries to unlock the power of the human microbiome, today announced the appointment of Joshua Brumm as chief financial officer. Mr. Brumm, an accomplished CFO with extensive [...]
BEDFORD, Mass., March 26, 2018 – Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries to unlock the power of the human microbiome, today announced the appointment of Stephen Sofen, Ph.D., as senior vice president of technical operations, and Susan Stewart, [...]